About Cholecystokinin receptor type A
Cholecystokinin receptor type A (CCKAR) is a protein
from Homo sapiens identified by UniProt accession
P32238, 428 residues long.
MolForge cross-references it against 0 known binders and
180 disease associations.
Target properties
| Protein name | Cholecystokinin receptor type A |
| UniProt accession | P32238 |
| Gene | CCKAR |
| Organism | Homo sapiens |
| Length | 428 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (6)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (180)
Diseases linked to this target (Open Targets).
- type 2 diabetes mellitus · score 0.37
- gastroesophageal reflux disease · score 0.37
- Peptic ulcer · score 0.37
- neurodegenerative disease · score 0.30
- irritable bowel syndrome · score 0.26
- glioblastoma multiforme · score 0.26
- breast adenocarcinoma · score 0.25
- appendicular lean mass · score 0.17
- BMI-adjusted waist-hip ratio · score 0.17
- waist-hip ratio · score 0.16
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P32238-F1 | alphafold | PREDICTED | 77.69 | — |
Amino-acid sequence (428 residues)
MDVVDSLLVN GSNITPPCEL GLENETLFCL DQPRPSKEWQ PAVQILLYSL IFLLSVLGNT LVITVLIRNK RMRTVTNIFL LSLAVSDLML CLFCMPFNLI PNLLKDFIFG SAVCKTTTYF MGTSVSVSTF NLVAISLERY GAICKPLQSR VWQTKSHALK VIAATWCLSF TIMTPYPIYS NLVPFTKNNN QTANMCRFLL PNDVMQQSWH TFLLLILFLI PGIVMMVAYG LISLELYQGI KFEASQKKSA KERKPSTTSS GKYEDSDGCY LQKTRPPRKL ELRQLSTGSS SRANRIRSNS SAANLMAKKR VIRMLIVIVV LFFLCWMPIF SANAWRAYDT ASAERRLSGT PISFILLLSY TSSCVNPIIY CFMNKRFRLG FMATFPCCPN PGPPGARGEV GEEEEGGTTG ASLSRFSYSH MSASVPPQ
Explore Cholecystokinin receptor type A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets